TIP60 inhibitors were efficacious in castrate-resistant prostate cancer and breast cancer in reducing proliferation and inducing apoptosis; however, to our knowledge TIP60 inhibition has not yet been applied as a therapeutic strategy for cancers that are specifically MYC-addicted [157,158]. The gene discussed is KAT5; the disease is breast carcinoma.